Table 4.
HBV group
(n = 51) |
Control group
(n = 102) |
P-value | |
---|---|---|---|
Female age (years) | 32.2 ± 4.2 | 32.0 ± 4.0 | 0.847a |
Female BMI (kg/m2) | 22.3 ± 2.9 | 22.4 ± 3.1 | 0.837a |
Duration of subfertility (years) | 4.1 ± 2.7 | 3.8 ± 1.9 | 0.705b |
Primary infertility (n, %) | 33/51 (64.7%) | 73/102 (71.5%) | 0.385c |
Cycle day-3 FSH (mIU/mL) | 5.6 ± 1.6 | 5.6 ± 1.4 | 0.921a |
Before preparation | |||
Sperm concentration (106/mL) | 62.8 ± 25.2 | 64.3 ± 22.1 | 0.722a |
Total progressive motile sperm count (*106) | 50.0 ± 31.6 | 69.2 ± 47.1 | 0.006 b |
After preparation | |||
Sperm concentration (106/mL) | 95.4 ± 53.0 | 106.8 ± 60.5 | 0.235a |
Total progressive motile sperm count (*106) | 23.5 ± 14.4 | 27.8 ± 17.4 | 0.104a |
Recovery rate (%) | 54.5 ± 35.5 | 45.2 ± 25.0 | 0.092b |
Clinical pregnancy rate (n, %) | 10/51 (19.6%) | 21/102 (20.5%) | 0.886c |
Abortion rate (n, %) | 1/10 (10.0%) | 3/21(14.2%) | 0.739c |
Values are presented as mean ± standard deviation.
P-values were obtained using aTwo-sided t-test, bWilcoxon rank sum test, or cChi-squared test.
HBV, Hepatitis B virus; BMI, body mass index; FSH, Follicle stimulating hormone. Bold values means they are statistically significant.